sars - cov -2的流行病学特征

V. Moskaliuk, B. V. Syrota, I. Balaniuk, N.V. Сhernetska, S. R. Melenko, T. Kolotylo
{"title":"sars - cov -2的流行病学特征","authors":"V. Moskaliuk, B. V. Syrota, I. Balaniuk, N.V. Сhernetska, S. R. Melenko, T. Kolotylo","doi":"10.24061/2413-0737.xxvi.2.102.2022.4","DOIUrl":null,"url":null,"abstract":"The Omicron strain was first registered by WHO in South Africa on November 24, 2021. As of early 2022, cases of Omicron had been registered in more than 60 countries and regions. The Omicron is currently the world's dominant strain of SAR-CoV-2 with a propensity to spread rapidly. Although diseases caused by Omicron are predominantly asymptomatic and mild, rapid growth or morbidity may seriously overwhelm the global health system. In addition to the above, its sources of mutations, the nature of infection transmission and its resistance to vaccines have not been fully studied yet. This insufficient knowledge leads to obstacles in the fight against a pathogen in different regions of the world. This article analyzes the results of the research on the characteristics of the pathogen, its variability, transmission characteristics and possible implementation mechanisms, epidemic status, prevention and other anti-epidemic measures to develop against the strain of SARCoV-2.","PeriodicalId":9270,"journal":{"name":"Bukovinian Medical Herald","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiological characteristics SAR-CoV-2 Omicron\",\"authors\":\"V. Moskaliuk, B. V. Syrota, I. Balaniuk, N.V. Сhernetska, S. R. Melenko, T. Kolotylo\",\"doi\":\"10.24061/2413-0737.xxvi.2.102.2022.4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Omicron strain was first registered by WHO in South Africa on November 24, 2021. As of early 2022, cases of Omicron had been registered in more than 60 countries and regions. The Omicron is currently the world's dominant strain of SAR-CoV-2 with a propensity to spread rapidly. Although diseases caused by Omicron are predominantly asymptomatic and mild, rapid growth or morbidity may seriously overwhelm the global health system. In addition to the above, its sources of mutations, the nature of infection transmission and its resistance to vaccines have not been fully studied yet. This insufficient knowledge leads to obstacles in the fight against a pathogen in different regions of the world. This article analyzes the results of the research on the characteristics of the pathogen, its variability, transmission characteristics and possible implementation mechanisms, epidemic status, prevention and other anti-epidemic measures to develop against the strain of SARCoV-2.\",\"PeriodicalId\":9270,\"journal\":{\"name\":\"Bukovinian Medical Herald\",\"volume\":\"31 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bukovinian Medical Herald\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24061/2413-0737.xxvi.2.102.2022.4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bukovinian Medical Herald","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24061/2413-0737.xxvi.2.102.2022.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

世卫组织于2021年11月24日在南非首次登记了欧米克隆毒株。截至2022年初,已在60多个国家和地区登记了欧米克隆病例。欧米克隆是目前世界上主要的sars - cov -2毒株,具有迅速传播的倾向。虽然由Omicron引起的疾病主要是无症状和轻微的,但快速增长或发病率可能严重压垮全球卫生系统。除上述外,其突变来源、感染传播的性质及其对疫苗的耐药性尚未得到充分研究。这种知识的不足导致在世界不同区域与病原体的斗争中出现障碍。本文就SARCoV-2的病原特征、变异、传播特征及可能的实施机制、流行现状、预防措施等方面的研究结果进行了分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epidemiological characteristics SAR-CoV-2 Omicron
The Omicron strain was first registered by WHO in South Africa on November 24, 2021. As of early 2022, cases of Omicron had been registered in more than 60 countries and regions. The Omicron is currently the world's dominant strain of SAR-CoV-2 with a propensity to spread rapidly. Although diseases caused by Omicron are predominantly asymptomatic and mild, rapid growth or morbidity may seriously overwhelm the global health system. In addition to the above, its sources of mutations, the nature of infection transmission and its resistance to vaccines have not been fully studied yet. This insufficient knowledge leads to obstacles in the fight against a pathogen in different regions of the world. This article analyzes the results of the research on the characteristics of the pathogen, its variability, transmission characteristics and possible implementation mechanisms, epidemic status, prevention and other anti-epidemic measures to develop against the strain of SARCoV-2.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PECULIARITIES OF ENDOTHELIAL DYSFUNCTION AND CAPILLARY BLOOD FLOW IN PATIENTS WITH COVID-19 CORONAVIRUS DISEASE AND CONCOMITANT TYPE 2 DIABETES MELLITUS THE IMPACT OF QUARANTINE AND SOCIAL ISOLATION ON THE MENTAL STATE OF THE POPULATION USE OF SURGICAL METHODS OF TREATMENT FOR THROMBOSIS OF THE INFERIOR VENA CAVA SYSTEM ASSOCIATION OF MARKERS OF LOW-GRADE INFLAMMATION IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION WITH TYPE 2 DIABETES MELLITUS: A COMPARATIVE ANALYSIS TELEMEDICINE AS A TOOL FOR OPTIMIZING AND IMPROVING METHODS OF PROVIDING MEDICAL AID TO THE POPULATION
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1